CDX2 + CK7 - Predilute - 6.0 ml
Pack Size: 1
Product DescriptionStudies show CDX2 is a sensitive marker for colonic carcinoma metastatic to the ovary and is more specific than CK20 as it is not expressed by serous and endometrioid carcinomas. CDX2 is also expressed in mucinous ovarian carcinomas. CDX2 is reported to be advantageous over CK20 for distinguishing primary ovarian tumours from metastases of upper gastrointestinal tract origin. Cytokeratin 7 shows expression in primary ovarian tumours and metastases of upper gastrointestinal tract origin. A CDX2 and CK7 panel may help in distinguishing colonic carcinomas metastatic to the ovaries from primary ovarian carcinomas.
• Intended Use: IVD
• Species Reactivity: Human
• Source: Mouse Monoclonal, Rabbit Monoclonal
• Clone: CDX2-88 + BC1
• ISOTYPE: Igg1 And Igg
• Antigen: CDX2 and CK7
• Localization: CDX2: (nuclear); brown CK7: (cytoplasmic); red
• Positive Control: Colon, breast, ovary and lung cancers
Additional information is not currently available.
Write Your Own Review